Phase IIa dose-escalating trial investigating the tolerability and pharmacokinetics of AV 1142742 in patients receving concomitant methotrexate for severe rheumatoid arthritis

Trial Profile

Phase IIa dose-escalating trial investigating the tolerability and pharmacokinetics of AV 1142742 in patients receving concomitant methotrexate for severe rheumatoid arthritis

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jun 2008

At a glance

  • Drugs AV 1142742 (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions; Biomarker; Pharmacokinetics
  • Most Recent Events

    • 11 Nov 2007 The clinical part of this trial is expected to be completed in the first half of 2008.
    • 25 Jan 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top